|
|
|
Weekly market: Market trend reverses to South after rising for 2 Weeks
|
|
Saturday, April 18, 2015 |
| | | Market Commentary | | | Market trend reverses to South after rising for 2 Weeks | | Indian stock markets slumped nearly 2% in the week gone led by global chaos which raised concerns for India's growth. The Sensex fell 1.51% and the Nifty was down by 1.98%. | |
 Major Headlines for the week:
Indian indices:
Welcome to the 'Weekly Market Wrap' for Saturday, April 18, 2015 where key benchmark indices declined in a truncated trading week ended 17 April 2015, as worries mounted that Greece's debt troubles could trigger an exit for the country from the eurozone and possibly financial contagion.
The recent rise in global crude oil prices also weighed on sentiment. The recent rise in global crude oil prices will raise concerns pertaining to India's fiscal deficit, current account deficit and fuel price inflation. The Sensex fell below the psychological 29,000 mark after regaining that mark at the start of the week. Key indices fell in three out of four sessions of the week.
The S&P BSE Sensex declined 437.28 points or 1.51% to settle at 28,442.10. The 50-unit CNX Nifty dropped 174.35 points or 1.98% to settle at 8,606.
The BSE Mid-Cap index shed 2.89%. The BSE Small-Cap index lost 1.89%. The fall in both these indcies was higher than Sensex's return in percentage terms.
Weekly market trend from April 13, 2015 - April 17, 2015:
April 13- Trading for the week started on a positive note. Telecom stocks and index heavyweight stocks led gains as key benchmark edged higher on the first trading session of the week on Monday. The Sensex rose 165.06 points or 0.57% to settle at 29,044.44 on that day, its highest closing level since 5 March 2015.
April 14- The stock market remained closed on Tuesday, on account of Dr. Baba Saheb Ambedkar Jayanti.
April 15- Pharma, telecom and realty stocks led losses for key benchmark indices on Wednesday. The Sensex dropped 244.75 points or 0.84% to settle at 28,799.69 on that day, its lowest closing level since 8 April 2015.
April 16- Pharma and cement stocks led losses as key benchmark indices edged lower for the second straight trading session on Thursday. The Sensex fell 133.65 points or 0.46% to settle at 28,666.04 on that day, its lowest closing level since 7 April 2015.
April 17- Key benchmark indices dropped on last trading session of the week on Friday, after  disappointing Q4 result from IT major TCS. The Sensex fell 223.94 points or 0.78% to settle at 28,442.10, on that day, its lowest closing level since 7 April 2015.
Global indices:
All the global markets ended in the mixed zone where Shanghai Composite surged 6.27%, Hang Seng rose 1.40% while DAX100 fell 5.54%, CAC40 dropped 1.85% and FTSE 100 slipped 1.34%
 Sectoral and stock screening:
All the sectors ended in the mixed zone where S&P BSE Oil&Gas rose 1.35%, S&P BSE Metal was up 0.44% and S&P BSE PSU surged 0.36% while S&P BSE Realty dropped 4.66%, S&P BSE HC was down 4.56% and S&P BSE IT slipped 4.06% | | Looking at the 'A' group stocks, the top three gainers of the week were: Gujarat Gas up 19.42%, Bayer CropScience up 16.83% and Atul up 12.00%
Top Losers: PMC Fincorp dipped 15.55%, MindTree dipped 15.25%, JustDial dipped 11.56%
FII/MF activity:
The foreign institutional investors (FIIs) have been the net buyers of the Indian stocks to the tune of Rs136.55 crore as on April 16, 2015 and the domestic investors bought Indian shares worth a net of Rs45.7 crore as on April 13, 2015.
| | TOP MOVERS (GROUP A) |  | | | | | | | | | | Bayer CorpScience | 3,886.15 | 16.83 | | | | | | | | | | | Just Dial | 1,169.70 | -11.56 | | | | | | | FII/MF ACTIVITIES | | | | | | | Gross purchase | 14,702 | 743 | | | | | | | | | | | | *Data as on April 16, 2015
**Data as on April 13, 2015
| | | | Market Outlook for the coming week!
In the coming week, the next batch of quarterly earnings of India Inc, proceedings of second half of budget session, macroeconomic data, trend in global markets, investment by foreign portfolio investors (FPIs), the movement of rupee against the dollar and crude oil price movement will dictate trend on the bourses in the coming week.
Stock-specific action will be seen as companies announce their earnings for the quarter ended 31 March 2015.
Developments during the second part of budget session of Parliament will be closely watched. The second part of the budget session will start after a month-long recess from 20 April 2015 to conclude on 8 May 2015.
On global front, Markit Economics will announce on Thursday, 23 April 2015, a preliminary reading of China's HSBC PMI index for April 2015, indicating health of China's manufacturing activity. Flash composite PMI indices for France, Germany and the euro zone for April 2015, will also be announced on that day. Markit flash US Manufacturing PMI index for April 2015 is also due on the same day.
In US, data on Chicago Fed National Activity Index (CFNAI), a monthly index designed to better gauge overall economic activity and inflationary pressure for April 2015 will be out on Monday, 21 April 2015.
| | | | To know more about our products and services, click here. |  | REGISTRATION DETAILS Regd Add: Sharekhan Limited, 10th Floor, Beta Building, Lodha iThink Techno Campus, Off. JVLR, Opp. Kanjurmarg Railway Station, Kanjurmarg (East), Mumbai - 400042, Maharashtra. Tel: 022 - 61150000. Sharekhan Ltd.: SEBI Regn. Nos. BSE - INB/INF011073351 ; BSE- CD ; NSE - INB/INF231073330 ; CD-INE231073330 ; MCX Stock Exchange - INB/INF261073333 ; CD-INE261073330 ; DP - NSDL-IN-DP-NSDL-233-2003 ; CDSL-IN-DP-CDSL-271-2004 ; PMS-INP000000662 ; Mutual Fund-ARN 20669 ; Commodity trading through Sharekhan Commodities Pvt. Ltd.: MCX-10080 ; (MCX/TCM/CORP/0425) ; NCDEX-00132 ; (NCDEX/TCM/CORP/0142) ; NCDEX SPOT-NCDEXSPOT/116/CO/11/20626 ; For any complaints email at igc@sharekhan.com ; Disclaimer: Client should read the Risk Disclosure Document issued by SEBI & relevant exchanges and Do's & Don'ts by MCX & NCDEX and the T & C on www.sharekhan.com before investing. | | | | "This document has been prepared by Sharekhan Ltd. (SHAREKHAN) and is intended for use only by the person or entity to which it is addressed to. This document may contain confidential and/or privileged material and is not for any type of circulation and any review, retransmission, or any other use is strictly prohibited. This document is subject to changes without prior notice. This document does not constitute an offer to sell or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction. Though disseminated to all customers who are due to receive the same, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is obtained from publicly available data or other sources believed to be reliable and SHAREKHAN has not independently verified the accuracy and completeness of the said data and hence it should not be relied upon as such. While we would endeavour to update the information herein on a reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees ("SHAREKHAN and affiliates") are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. This document is prepared for assistance only and is not intended to be and must not alone be taken as the basis for an investment decision. Recipients of this report should also be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as he deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult his own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of SHAREKHAN may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licencing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction. Either SHAREKHAN or its affiliates or its directors or employees/representatives/clients or their relatives may have position(s), make market, act as principal or engage in transactions of purchase or sell of securities, from time to time or may be materially interested in any of the securities or related securities referred to in this report and they may have used the information set forth herein before publication. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. The analyst certifies that all of the views expressed in this document accurately reflect his or her personal views about the subject company or companies and its or their securities and do not necessarily reflect those of SHAREKHAN. Further, no part of the analyst's compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this document." Compliance Officer: Ms. Namita Amod Godbole; Tel: 022-6115000; e-mail: compliance@sharekhan.com
Contact: myaccount@sharekhan.com | | | |
|
posted by Anonymous @ 2:14 AM  |
|
|
|
|
|
